Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline PK and Safety in Children 8-11 Years with Serious Infections
NCT00488345Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2007
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of tigecycline in Intra-abdominal infection (IAI), Complicated skin and skin structure infection (cSSSI), community acquired pneumonia (CAP), sponsored by Pfizer. Started Dec 2007; status: completed.
02
Drugs
tigecycline
03
Conditions
Intra-abdominal infection (IAI)Complicated skin and skin structure infection (cSSSI)community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00488345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488345.